Shanthi Marur

Oncology

401 N Broadway St
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 11, 2025

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 31, 2023

Evaluating Cancer Drugs in Patients With Central Nervous System Metastases.

Evaluating Cancer Drugs in Patients With Central Nervous System Metastases.

Journal: JAMA oncology

Published: April 15, 2021

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 05, 2018

FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.

FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.

Journal: Seminars in oncology

Published: July 20, 2018

Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.

Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: March 24, 2018

Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials.

Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 22, 2017

Reply to A. Garden et al.

Reply to A. Garden et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 22, 2017

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 29, 2016

Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60-66].

Corrigendum to "Cetuximab activity in dysplastic lesions of the upper aerodigestive tract" [Oral Oncol. 53 (2016) 60-66].

Journal: Oral oncology

Published: April 18, 2016

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

Journal: Mayo Clinic proceedings

Published: October 30, 2015

A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.

A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: September 24, 2015

Showing 1-12 of 26

Last Updated: 09/26/2026